| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 23, 2023 | May 25, 2023 | Prelude Therapeutics Inc | CFO | Buy | 91.3 | +5,000 | 13.45% | ✗ | $27.5K |
| Dec 8, 2022 | Dec 12, 2022 | Prelude Therapeutics Inc | CFO | Buy | 91.3 | +10,000 | 38.65% | ✗ | $47.6K |
| Jun 1, 2022 | Jun 1, 2022 | Prelude Therapeutics Inc | CFO | Buy | 91.3 | +10,000 | 68.97% | ✗ | $42.3K |